CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for HEM Pharma Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

HEM Pharma Inc
Phone: +82 542603122p:+82 542603122 POHANG, 37554  South Korea Ticker: 376270376270
Business Summary
HEM Pharma Inc is a Korea-based company primarily provides customized healthcare solution services based on personalized pharmaceutical metal-analytical screening (PMAS) technology. The Company mainly operates two businesses. The customized healthcare services business mainly researching and discovery the relationship between diseases and human body’s various microbiota and beneficial substances produced by microorganisms to provide the optimal solution for individuals. The live biotherapeutic products (LBP) discovery platform service business mainly provides disease biomarker verification, disease-specific animal model design, finished drug production and microbial safety evaluation services.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023-----

Industries
SIC Code Description
8731 Commercial physical and biological research

General Information
Outstanding Shares: 6,952,039 (As of 11/5/2024)
Stock Exchange: KDQ
Fax Number: +82 3151866074


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024